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AbstrACt
Cancer is an emerging public health problem in sub-
Saharan Africa due to population growth, ageing and 
westernisation of lifestyles. The increasing burden of 
cancer calls for urgent policy attention to develop cancer 
prevention and control programmes. Cancer surveillance is 
an essential prerequisite. Only one in five low-income and 
middle-income countries have the necessary data to drive 
policy and reduce the cancer burden. In this piece, we use 
data from Mozambique over a 50-year period to illustrate 
cancer epidemiological trends in low-income and middle-
income countries to hypothesise potential circumstances 
and factors that could explain changes in cancer burden 
and to discuss surveillance weaknesses and potential 
improvements. Like many low-income and middle-income 
countries, Mozambique faces the dual challenge of a still 
high morbidity and mortality due to infectious diseases in 
rural areas and increased incidence of cancers associated 
with westernisation of lifestyles in urban areas, as well as 
a rise of cancers related to the HIV epidemic. An increase 
in cancer burden and changes in the cancer profile should 
be expected in coming years. The Mozambican healthcare 
and health-information systems, like in many other low-
income and middle-income countries, are not prepared 
to face this epidemiological transition, which deserves 
increasing policy attention.
IntroduCtIon
Cancer is an emerging public health problem 
in sub-Saharan Africa.1 According to GLOB-
OCAN 2012 estimates, there were 626 399 new 
cancer cases in sub-Saharan Africa in 2012, 
which represents 4.4% of the 14.1 million 
worldwide new cancer cases and almost the 
same number of estimated cancer cases in 
2008 for the whole African Region (667 000 
incident cases). Regarding mortality, 5.5% 
of the 8.2 million estimated deaths in 2012 
occurred in sub-Saharan Africa (447 745 
deaths), again close to the 518 000 deaths 
estimated in 2008 for the whole African 
Region.2 3 This increase is partly related to 
population growth and ageing, but also to 
westernisation of lifestyles.1 4 Although 25% 
of all cancers in low-income and middle-in-
come countries (LMIC) are still estimated to 
be infection related,2 societal and economic 
development is linked to behavioural and life-
style changes, associated with conventional 
industrialised countries cancer risk factors. 
For this reason, an epidemiological transition 
is expected in many low-resourced settings, 
with profound effects on the magnitude and 
profile of the cancer burden.4 Unquestion-
ably, this will have major implications for 
public health and clinical services planning 
Key questions
What is already known about this topic?
 ► Cancer is an emerging public health problem in 
low-income and middle-income countries due to 
population growth, ageing and westernisation of 
lifestyles.
What are the new findings?
 ► The increasing cancer burden will have major 
implications for public health and clinical services 
planning and a great impact in low-income and 
middle-income countries without strong health 
systems.
 ► Healthcare and health-information systems in 
countries like Mozambique might not be prepared 
to face this epidemiological transition.
recommendations for policy
 ► Cancer deserves increasing policy attention. 
Countries like Mozambique should work 
simultaneously in population awareness, the 
establishment of a national cancer registry and 
demographic information with higher quality and 
coverage and the strengthening of health systems 
to implement cancer prevention and control 
programmes. 
 ► Development of networks and coordination with 
organisations providing support and sharing 
knowledge such as the Global Initiative for Cancer 
Registry Development should be prioritised.
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and a great impact in LMIC without strong health systems, 
which at the same time, are also expected to experience 
the greatest proportional population growth in the next 
years and, thus, the greatest increase in cancer burden.
Cancer surveillance with robust statistics on cancer 
incidence, morbidity, survival and mortality, is an essen-
tial prerequisite for national and regional cancer control 
programmes. It is also essential for targeted operational 
research outputs. However, there is a lack of vital statis-
tics and population-based registries in LMIC.4 An encour-
aging step forward is The Global Initiative for Cancer 
Registry Development (GICR), a coordinated, multi-
partner approach that aims to reduce the incidence, 
mortality and suffering due to cancer in the world’s 
poorest regions through high-quality data that inform 
cancer control. According to GICR, only one in five 
LMICs have the necessary data to drive policy and reduce 
the burden and suffering due to cancer.5
A global view of cancer patterns and trends in relation 
to national level of development becomes an imper-
ative to understand changes in the cancer burden and 
its major causes and to raise policy attention to develop 
control and prevention strategies. The aim of this piece 
is to illustrate these challenges using the example of 
cancer epidemiological trends in a low-income country, 
to hypothesise potential circumstances and factors that 
could explain the cancer burden changes and to discuss 
surveillance weaknesses and potential improvements. For 
that, we use the case of Mozambique, one of the poorest 
countries in sub-Saharan Africa, but with fast social and 
economic development.
We analysed socioeconomic changes, cancer epide-
miological trends, weaknesses and potential strengths 
for cancer surveillance over a 50-year period. Epidemi-
ological data were mainly obtained from two big cancer 
surveys, which cover today’s Maputo City area for the 
periods 1956–19616 and 1991–2008,7 respectively.
tHe exAmple of mozAmbIque
fifty years of important social and economic changes
In 1956, Mozambique was still a Portuguese colony. 
Lourenço Marques (today Maputo city) was a commer-
cial and administrative centre and a busy port with a 
population of about 100 000.8 The city was undergoing 
the simultaneous process of urbanisation, detribalisation 
and assimilation of Western culture. Mozambique already 
had one of the least developed colonial economies when, 
in 1975, it gained independence. After independence, 
Mozambique quickly constructed a primary healthcare 
system based on principles defined at the transforma-
tive 1978 Alma-Ata conference,9 but 16 years of civil war 
destroyed infrastructures, ruined livelihoods and severely 
hampered agricultural production and economic devel-
opment.10 The conflict and the subsequent natural disas-
ters (severe floods and droughts) forced the internal 
and external displacement of many families. Since the 
first multiparty election of 1994, the economy has been 
recovering with some of the fastest growth rates in the 
world.11
Mozambique, a malaria endemic country, has also been 
hard hit by the HIV and tuberculosis dual epidemic,12 
which compromises the country’s social and economic 
progress. Since the 1990s, the HIV has shown an extremely 
rapid progression, affecting, in some settings, up to 45% 
in women aged 28–47 as reported in a recent commu-
nity-based study in a rural district of Maputo province.13
Despite more than 20 years of relatively stable political 
context, Mozambique is still one of the world’s poorest 
countries, with a Human Development Index of 0.461 
(ranking at 180 out of 188 countries) and 44.1% of 
population in severe multidimensional poverty.14 Since 
the start of the first nationwide education and literacy 
campaign in 1975, the adult illiteracy rate has notably, 
but not sufficient, decreased from 97% to 56%.6 15 Life 
expectancy remains low, although from 1960 to 2008 
raised from 35 to 52.2 years.16 Nowadays, the country is 
facing the consequences of urbanisation and westerni-
sation of lifestyle, which coexist with an extremely high 
burden of traditional infectious diseases of poverty, a new 
political crisis, an important economic instability and a 
fragile and under-resourced health system.1 9 11 17 Since 
the structural adjustment programme sponsored by the 
International Monetary Fund to pay back debt in 1987, 
Mozambique’s health system has been struggling with 
the huge cuts to public spending and the constraint of 
foreign aid for strengthening the national health system.9
Cancer patterns and trends in mozambique
Although cancer surveillance data in Mozambique is still 
far away from desired standards, the availability of two 
big cancer surveys in today’s Maputo area for the periods 
1956–1961 and 1991–2008 is uncommon compared with 
other LMIC. As summarised in table 1, there are signifi-
cant methodological limitations that restrict the compar-
ison and trend analysis of available data; even so, we 
believe that a cautious analysis can provide valuable infor-
mation to address the cancer challenges in Mozambique.
Cancer incidence rates have varied considerably 
during the last decades in Maputo, as shown in table 2. 
We observe an increase from 169.9 cases per 100 000 in 
1956–1961 to 182.7 in 1991–2008 in men and from 95.3 to 
186.0 cases per 100 000 in women. Although the different 
age distributions standards used in both assessments can 
hinder precise comparisons between different popula-
tions considerably, there is no doubt that the cancer noti-
fication rates in Mozambique have generally experienced 
a remarkable increase. Whereas between 1956 and 1961, 
a total of 600 cancers (403 in men, 197 in women) were 
registered, between 2003 and 2008, 6743 cases of cancer 
were identified (2900 in men, 3818 in women and 25 
people without gender information).6 7
This startling increase in absolute numbers of more 
than seven times in men and more than 19 times in 
women may be related to different processes. First of all, 
Maputo had a population of about 100 000 in the early 
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1960s,8 which increased markedly until the 2007 census 
where it reached 1 094 628 inhabitants. In addition, 
cancer is an affliction that normally occurs later in life. 
From 1960 to 2008, the life expectancy in Mozambique 
raised from 35.0 to 52.2 years. Furthermore, improve-
ments in education and healthcare access and the intro-
duction of new diagnostic techniques may have played 
a role in increased cancer detection. Prates and Torres6 
mentioned that men used healthcare services for general 
treatment more frequently than women did, although 
most women stated that if sick they would seek treatment 
at a clinic or hospital. The authors suggested that the 
reduced access to healthcare in women could be related 
to the fact that by that time, before making a decision, 
women must obtain permission from the head of the 
family who could have been absent as a migrant labourer. 
Increased women’s access to maternal and reproduc-
tive health services, evidenced by the gradual reduction 
in maternal mortality, could also explain the increased 
notification rates in women observed by Lorenzoni and 
colleagues.7
Regarding to the specific cancer burden profile, today 
Mozambique presents, as many other LMIC, a dual 
burden with a still high incidence of cancers associated 
with infectious diseases and an increasing incidence of 
cancers related to lifestyle risk factors. In the last decades, 
the country has experienced important downward trends 
in infection-related cancers such as primary carcinoma 
of the liver or cancer of the urinary bladder, but unfortu-
nately, HIV-related cancers have experienced a substan-
tial increase. As expected due to the westernisation of 
lifestyles, some of the most common cancers in high-in-
come countries, such as prostate or breast cancer, have 
experienced enormous increase in Mozambique. Such 
trend has not been observed in lung cancer incidence, 
which remains still low. Prates and Torres (1956–1961) 
recorded the highest incidence of primary carcinoma of 
the liver for any part of the world, with age-standarised 
Table 1 Methodological differences between the two surveys that restrict the comparison and trend analysis of data
Survey 1956–1961 Survey 1991–2008
Covered area Urban and periurban area of about 60 km2 at that time 
Lourenço Marques (today’s Maputo city).
Today’s Maputo city
Type of registry Population-based registry: it included every tumour 
diagnosed in Miguel Bombarda Hospital (MBH), the 
two missionary hospitals and the outpatient’s clinics 
(private and state controlled) in Lourenço Marques. 
Data of new cancer cases were obtained of biopsies 
and autopsies performed by the department of 
pathology of the MBH, but also of home visits.
Laboratory-based registry: it included all 
tumours diagnosed by anatomopathological 
test performed in the department of 
pathology of the Maputo Central Hospital. 
The department also receives samples of 
other public and almost all private health units 
in the city.
Population estimates Due to the steady influx of African rural workers 
seeking employment in Lourenço Marques, the 
1950 census was even more inadequate than 
African census records usually are.6 In 1957–1958, a 
sample survey was conducted to ascertain accurate 
demographic data. At that time, there were no house 
numbers or guiding maps, random sampling was done 
using aerial photographs and included the three main 
residential strata at that time: servants and labourers 
living on employers’ premises in central area of the 
town, suburban dwellers living in their own houses 
on the immediate outskirts of the central area and 
periurban population. A total of 4291 men and women 
were included to calculate the population estimates of 
age and sex distribution.
The first postcivil war Mozambican census 
was performed in 1980. Although their 
precision can be questioned, data of the 
1980, 1987 and 2007 census were available 
and intercensual estimates could be 
calculated.




Due to the high illiteracy rate at the time (97% before 
the first literacy campaign in 1975), estimating 
patients’ age was a big challenge. Surveyors were 
specially trained to establish the age by questioning 
about critical periods or historical events.
Age-standardised rates were calculated using the 
Standard African Population, a less westernised 
standard adequate for comparison with other 
territories of Africa.
The World Standard Population proposed by 
Segi (1960) was used for age standardisation. 
This standard is widely adopted, but it 
reflects to a greater extent population with 
relatively low fertility and mortality giving more 
weight to the middle years of life. Applying 
this standard to ‘younger’ populations can 
misstate the true level of estimates.38
Extrapolation of data In both cases, surveys were restricted to today’s Maputo city area. Information of other sites of the 
country and especially of rural areas is needed for a national-wide extrapolation.
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rates (ASR) per 100 000 of 109.7 for males and 14.1 for 
females. Cancer of the liver affected mostly the young 
men population between ages 15 and 44. Age-spe-
cific incidence rate reached 264.0 per 100 000 in males 
between 40 and 44 years and 81.5 in women of the same 
age. Aflatoxin contamination of foodstuffs and chronic 
carriage of hepatitis B virus (HBV) were considered as 
major factors to develop cancer of the liver.18 In the last 
decades, incidence of liver cancer in Maputo has shown 
a marked continuous decrease, being the ASR, for the 
period 2003–2008,  28.8 and 8.3 per 100 000 in men 
and women, respectively. In a study conducted in 1985 
in Mozambique and in the former Republic of Transkei, 
the aflatoxin levels observed in food samples were the 
highest ever recorded in any part of the world.18
Aflatoxin levels continue to be high in Mozambique.19 
Its exposure may have decreased through (1) campaigns 
about the dangers of mouldy food, which is likely to have 
resulted in increased selectivity during the preparation 
of foodstuffs, (2) the reduction of peanuts consumption 
due to economic pressure18 and (3) nutrition transition, 
incrementing animal source food consumption, which 
probably has replaced groundnuts as the traditional 
main protein source.20 21 Although aflatoxin alone does 
increase the risk of liver cancer, the risk is much greater 
in carriers of HBV.22 HBV vaccination was introduced in 
Mozambique in 2001 and according to WHO, estima-
tions of National coverage rates range from 74% to 76%. 
It may be too early to evaluate the effectiveness of this 
intervention, but a further decrease in the incidence of 
liver cancer should be expected in the upcoming years.
Cancer of the urinary bladder  was the second most 
frequent cancer in males and third in females in the 
1956–1961 period, with most of the cancers being 
squamous cell carcinomas, a histological variety closely 
associated with urinary schistosomiasis infection.23 Inter-
estingly, this cancer has shown a marked decrease, which 
could be related to the reduction in the prevalence of 
schistosomiasis, which has been recently described in 
southern Mozambique.24
Unquestionably, the HIV epidemic has had a signifi-
cant impact on Maputo’s cancer profile. AIDS-defining 
neoplasm such as cervical cancer and Kaposi’s sarcoma 
(KS) have constantly increased since 1990.7 Cancer of 
the uterine cervix was the second most frequent cancer in 
women in the 1950s and has become the most frequent 
neoplasm in the 2000s with an ASR per 100 000 of 62.2, 
one of the highest cervical cancer rates worldwide.1 The 
social disruption caused by the civil war in the 1970s 
and 1980s may have favoured the spread of human 
Table 2 Age-standardised incidence rates (per 100 000) in the periods from 1956 to 1961 and 2003–2008.
Males Females
Age-standardised rate per 100 000 Age-standardised rate per 100 000
1956–1961* 2003–2008† 1956–1961* 2003–2008†
Total, all sites 169.9 182.7 95.3 186.0
Oral cavity, pharynx 3.8 5.0 4.8 4.5
Oesophagus 3.2 8.7 – 9.9
Stomach 1.0 1.6 0.6 1.0
Colon–rectum 2.0 6.3 0.7 2.7
Liver 109.7 14.1 28.8 8.3
Pancreas 0.9 0.4 0.7 0.3
Trachea, bronchus, lung 3.2 2.6 2.5 1.7
Other connective and soft tissue 3.8 4.4 1.7 3.1
Breast – – 2.4 26.2
Uterine cervix – – 20.3 62.0
Other tumours of the female genital 
tract
– – 4.0 10.8
Prostate 3.4 61.7 – – 
Penis 2.1 3.6 – – 
Kidney 0.9 0.9 0.7 1.3
Bladder 11.1 4.0 10.0 2.9
Conjunctiva 1.8 4.7 3.2 6.3
Malignant lymphomas (all types) 6.9 9.1 2.8 6.7
Kaposi’s sarcoma 2.9 25.0 – 12.0
*Age-standardised rate per 100 000 considering African Standard Population.
†Age-standardised rate per 100 000 considering World Standard Population proposed by Segi (1960).
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papillomavirus (HPV) infection and other sexually 
transmitted infections (STI). Although unusual, KS had 
already been detected in the Mozambican population in 
the 1950s, similar to other countries in Africa. However, 
in the 1950s, it was of the typical ‘endemic’ pattern, 
involving the skin, particularly the legs, and affecting 
males, with the risk rising progressively with age.25 The 
enormous increase in the incidence of this cancer since 
the earlier periods,26 together with the narrowing of the 
sex ratio has previously been reported in Uganda.27
Improvements in the control of HIV and in other STI, 
such as increased HIV testing and antiretroviral therapy 
coverage or HPV vaccination (to be implemented 
nationally in the coming years), and increased coverage 
of population screening should stagnate and decrease 
current numbers of HIV-related and STI-related cancers.
Prostate cancer is the most commonly diagnosed cancer 
among men in Southern Africa and Western Africa. In 
Maputo, prostate cancer was rarely diagnosed in the 
1950s, whereas in the 2000s, the incidence reaches 61.7 
cases per 100 000, four times the rate reported for sub-Sa-
haran Africa. Being a cancer that almost always appears 
late in life, life expectancy can doubtless explain part of 
the big rate increase. Screening programmes are unlikely 
to have played a role, but it is possible that increased 
awareness and use of diagnostic and therapeutic proce-
dures in patients with persistent urinary symptoms have 
contributed to the increase observed in its occurrence. 
Due to the observed racial disparities in prostate cancer 
risk with higher rates reported among African descen-
dants, genetic susceptibility has been suggested to play 
a role.28
Breast cancer was rarely diagnosed in Mozambique in 
the 1950s, while its incidence has increased almost 10 
times in the 2000s. In many sub-Saharan African coun-
tries, breast cancer has now become the most commonly 
diagnosed cancer. Beyond enhanced detection, reasons 
for this are unknown, but increases in the prevalence 
of risk factors for breast cancer such as early menarche, 
late childbearing, low parity, obesity, which are associ-
ated with urbanisation and economic development have 
certainly played an important role.1 Nonetheless, the 
ASR of breast cancer in Maputo remains relatively low 
compared with global figures.29 30
Finally, the increase in the incidence of cancer of the 
oesophagus observed in both sexes between the 1950s and 
2000s is difficult to explain. A similar increase has been 
observed in Uganda.27 Alcohol, tobacco and cereal-based 
diets, particularly those relying on maize via nutritional 
deficiencies associated with such diets or contamina-
tion of maize with mycotoxins may have a role in this 
phenomenon.27
Challenges and limitations of cancer surveillance
High-quality cancer surveillance is crucial to fight the 
cancer epidemic in LMIC. Vital statistics, risk factor 
surveys and population-based cancer registries are funda-
mental for cancer surveillance.31 The vital statistics system 
of Mozambique has been virtually unchanged for more 
than 50 years. Although there is a comprehensive system 
for registering births, deaths and other vital events, its 
coverage and quality are discouragingly low to merit any 
attempt to use these data for statistics.32 Digitalisation, 
more accurate information and coverage enhancement 
are needed. Coverage might be improved by imme-
diate registration of all births and deaths taking place in 
hospitals, preliminarily registration of newborn babies 
who have not been given a name and allowing unmar-
ried mothers to register their child, regardless the father 
is away, refuses or is unknown. The lack of an address 
system and the lack of registered data on migrations 
within Mozambique as well as to and from other coun-
tries, make demographic estimates even more difficult.32
Mozambique does not have a national popula-
tion-based cancer registry. The first Mozambican popula-
tion-based cancer registry started in Maputo in the 1960s, 
but disappeared after the independence. After the end 
of civil war in 1991, the Department of Pathology at the 
Maputo Central Hospital (MCH, named during the colo-
nial period Miguel Bombarda Hospital) restarted the 
registration of all cancers with anatomopathological diag-
nosis. The MCH performed all the pathological testing in 
the country until 2001, when a Department of Pathology 
was established at the Hospital Central de Beira, covering 
the central region of the country. In 2003, the Hospital 
Central de Nampula, in charge of the north region, also 
opened a Pathology Department. Today, the city of Beira 
has a population-based cancer registry and the Depart-
ment of Pathology at the MCH continues with its registry.
According to the key elements of population-based 
registries for cancer incidence surveillance proposed by 
Piñeros et al,31 Mozambique faces several challenges to 
implement a national population-based registry. First, 
although after the end of civil war, censuses have been 
performed in 1980, 1997 and 2007 and intercensual esti-
mates are available, their precision can be questioned 
because of the long-time periods between rounds or the 
fluctuating migration patterns. In fact, demographic 
surveillance platforms were developed in some settings 
in order to have more accurate population figure.33
As a second key element, existence and development 
of oncological services, access to medical and diagnostic 
services and quality of medical information should be 
improved. According to the Mozambique Poverty Reduc-
tion Strategic Programme II,34 only 36% of people have 
access to a health facility within 30 min of their homes. 
About 30% of the population is not able to access health 
services and only 50% have access to an acceptable level 
of healthcare. There is a need for more investment in 
health system structures and functions. Many health facil-
ities are in urgent need of renovation and maintenance, 
with lack of basic commodities such as running water, 
electricity, transport or communication.35 But the biggest 
barrier is the lack of trained human resources capacity. 
Mozambique has one of the lowest health worker densi-
ties in Africa, with three doctors and 21 nurses per 
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100 000 inhabitants.36 There are only seven oncologists 
in the country and no oncological surgeons. Even so, 
the country is doing significant efforts to improve cancer 
diagnosis and treatment through capacity building activ-
ities, including increased number of trained special-
ists, improved infrastructures and equipment.37 As an 
example, immunohistochemistry was introduced in 1993 
and fine needle aspiration biopsy assessment in 1996.
Finally, access to information sources and consolida-
tion of data from multiple sources are needed to achieve 
an efficient population-based cancer registry. The 
Health Information System in Mozambique is still facing 
numerous challenges in terms of quality and use of data, 
mainly due to insufficient and poorly trained health 
workers, scarce financial resources, inadequate tools for 
data management and inadequate supervision and feed-
back.35 The recent evolution of surveillance of non-com-
municable diseases (NCDs), including cancer, has 
emphasised risk factor surveillance rather than disease 
occurrence,36 which could be improved by strengthening 
health information systems and health surveys. Mozam-
bique joined the Demographic Health Surveys Program 
on 1997 and finished the third round on 2011. These 
surveys provide very valuable data but are mainly focused 
on communicable diseases and maternal and child 
health. Incorporation of NCDs and its risk factors would 
be of paramount importance.
ConClusIon
An increase in cancer burden (both in notifications and 
real incidence) and changes in the cancer profile should 
be expected in LMIC in the upcoming years, due to the 
constant growth of population, the higher life expectancy 
and the increased prevalence of economic transition-as-
sociated risk factors.
The case study of Mozambique shows how the country 
faces the dual challenge of a still high morbidity and 
mortality due to infectious diseases in the rural areas and 
the increased incidence of cancers associated with west-
ernisation of lifestyles in urban areas, as well as a rise of 
cancers related with the HIV epidemic. In addition, the 
Mozambican healthcare and health-information systems 
are not prepared to face this epidemiological transition, 
which deserves increasing policy attention. Similar situa-
tions can be expected in other LMIC undergoing a rapid 
societal and economic transition.
Involvement of all stakeholders, such as the Govern-
ment, the Health Department, the international organ-
isations, the non-profit organisations working in LMIC, 
as well as the general population is needed to promote 
a holistic and equitable approach of this public health 
priority. Population awareness, the development of an 
accurate and comprehensive cancer surveillance system, 
including the establishment of a national cancer registry 
coupled with precise demographic information, the 
implementation of effective primary prevention strategies 
and early detection programmes, improved diagnostic 
techniques and high-quality medical services are essen-
tial to monitor and control the cancer epidemic. It is of 
particular importance to pay special attention to rural 
areas and other vulnerable populations. Development of 
networks and coordination with organisations providing 
support and sharing knowledge such as the Global 
Initiative for Cancer Registry Development should be 
prioritised.
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